Find research datasets worth reusing

Global Prevalence of ATTR-CM in Participants With HFpEF

ClinicalTrials.gov study NCT04424914. IPD Sharing: NO. Countries: 8. Publications: 1.

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

ClinicalTrials.gov study NCT04814186. IPD Sharing: YES. Countries: 1. Publications: 1.

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

ClinicalTrials.gov study NCT05635045. IPD Sharing: NO. Countries: 1. Publications: 1.

APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

ClinicalTrials.gov study NCT03997383. IPD Sharing: YES. Countries: 22. Publications: 2.

Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

ClinicalTrials.gov study NCT04535349. IPD Sharing: NO. Countries: 1. Publications: 1.

ATTR-CM: A Multi-country, Non-interventional Disease Registry

ClinicalTrials.gov study NCT06651073. IPD Sharing: NO. Countries: 1. Publications: 1.

ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

ClinicalTrials.gov study NCT07314268. IPD Sharing: Not stated. Countries: 1. Publications: 23.

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

ClinicalTrials.gov study NCT07196839. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

ClinicalTrials.gov study NCT06465810. IPD Sharing: YES. Countries: 5. Publications: 1.

ATTR Amyloidosis in Elderly Patients With Aortic Stenosis

ClinicalTrials.gov study NCT04061213. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

ClinicalTrials.gov study NCT05374564. IPD Sharing: NO. Countries: 1. Publications: 26.

A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

ClinicalTrials.gov study NCT03336580. IPD Sharing: NO. Countries: 4. Publications: 1.

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

ClinicalTrials.gov study NCT06355934. IPD Sharing: YES. Countries: 10. Publications: 1.

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

ClinicalTrials.gov study NCT04988386. IPD Sharing: UNDECIDED. Countries: 17. Publications: 2.

Phenotypic Manifestations of Hereditary ATTR Amyloidosis

ClinicalTrials.gov study NCT07124377. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.

ClinicalTrials.gov28/100

A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM

ClinicalTrials.gov study NCT04622046. IPD Sharing: NO. Countries: 1. Publications: 0.

ClinicalTrials.gov28/100

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

ClinicalTrials.gov study NCT05667493. IPD Sharing: YES. Countries: 20. Publications: 0.